175 related articles for article (PubMed ID: 29758320)
1. Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report.
Nagumo Y; Maejima A; Toyoshima Y; Komiyama M; Yonemori K; Yoshida A; Fujimoto H
Int J Surg Case Rep; 2018; 48():1-4. PubMed ID: 29758320
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder.
Hensley PJ; Bree KK; Guo CC; Lobo N; Campbell MT; Pettaway CA; Kamat AM
BJU Int; 2022 Nov; 130(5):604-610. PubMed ID: 34773684
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Myofibroblastic Tumour of the Urinary Bladder in a Middle-Aged Man-A Case Report of an Unusual Localization of a Rare Tumour.
Prijovic N; Santric V; Babic U; Stankovic B; Acimovic M; Cekerevac M; Nikolic G; Cegar B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109749
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
5. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
[TBL] [Abstract][Full Text] [Related]
7. ALK Gene Translocation in Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report.
Takagi K; Takai M; Kameyama K; Horie K; Kikuchi M; Kato T; Mizutani K; Seike K; Tsuchiya T; Yasuda M; Yokoi S; Suzui N; Nakano M; Deguchi T
Urol Case Rep; 2015 Sep; 3(5):138-40. PubMed ID: 26793530
[TBL] [Abstract][Full Text] [Related]
8. Robot-assisted Partial Cystectomy for Treatment of Inflammatory Myofibroblastic Tumor of the Bladder.
Rotenberry C; Dowd K; Russell D; DeRiese W; Teeple S; Cammack T
Urol Case Rep; 2017 Feb; 11():25-27. PubMed ID: 28083481
[TBL] [Abstract][Full Text] [Related]
9. Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
Lowe E; Mossé YP
Oncol Ther; 2024 Apr; ():. PubMed ID: 38676786
[TBL] [Abstract][Full Text] [Related]
10. Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review.
Durham C; Clemons M; Alias A; Konduri K
Cureus; 2022 Jul; 14(7):e27223. PubMed ID: 36035049
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
[TBL] [Abstract][Full Text] [Related]
12. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report.
Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC
Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035
[TBL] [Abstract][Full Text] [Related]
14. Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report.
Comandini D; Catalano F; Grassi M; Pesola G; Bertulli R; Guadagno A; Spina B; Mascherini M; De Cian F; Pistoia F; Rebuzzi SE
Front Oncol; 2021; 11():658327. PubMed ID: 34211840
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Inflammatory Myofibroblastic Tumor of Urinary Bladder].
Tanaka K; Ikeda A; Miyakawa T; Komine M; Tsutsumi M; Ishikawa S; Kawai K; Nishiyama H
Hinyokika Kiyo; 2016 Apr; 62(4):201-4. PubMed ID: 27217015
[TBL] [Abstract][Full Text] [Related]
16. A rare huge bladder inflammatory myofibroblastic tumor treated by en bloc resection with diode laser: a case report and literature review.
Yuan H; Wang Z; Sun J; Chu J; Duan S; Wang M
Front Oncol; 2024; 14():1327899. PubMed ID: 38529377
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring
Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z
Front Oncol; 2023; 13():1147974. PubMed ID: 37035208
[TBL] [Abstract][Full Text] [Related]
18. Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child.
Reyes-Angel J; Rapkin LB; Simons JP; Muzumdar H
Pediatr Pulmonol; 2022 Jan; 57(1):330-332. PubMed ID: 34710285
[TBL] [Abstract][Full Text] [Related]
19. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
[TBL] [Abstract][Full Text] [Related]
20. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
